Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same
The existent therapeutic drugs for CNV are merely pharmaceuticals for a symptomatic therapy, and therapeutic drugs for radical cure are strongly demanded. Also, a therapeutic drug for Dry AMD does not exist, and therapeutic drugs for radical cure are strongly demanded. The present invention provides...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Mizunuma, Hidemi Takai, Yoshihiro Mitsuguchi, Yoko Ogura, Dai Kurose, Takahiro Moriya, Mariyo Arai, Yoko Niwa, Shinichiro |
| description | The existent therapeutic drugs for CNV are merely pharmaceuticals for a symptomatic therapy, and therapeutic drugs for radical cure are strongly demanded. Also, a therapeutic drug for Dry AMD does not exist, and therapeutic drugs for radical cure are strongly demanded. The present invention provides a prophylactic and/or therapeutic agent for choroidal neovascularization, containing a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient. Also, the present invention provides a drusen suppressor comprising a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10761087B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10761087B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10761087B23</originalsourceid><addsrcrecordid>eNqNi7EKwkAQRNNYiPoPa6-QKBhrg2Kv1mHJbZKDZPfYTVL49ebAykoYGIb3ZplMRSsq3mEHTDKhVWOH6t84eGGwMQQlM1GY43Q0YqhF-1-8A2QHPQ2tuCgAms3AcxOPVikRxxGRYU_rZFFjZ7T59irZ3q7P4r6nICVZwIqYhvL1yNL8lKXn_HI4_uN8ABW5RxM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same</title><source>esp@cenet</source><creator>Mizunuma, Hidemi ; Takai, Yoshihiro ; Mitsuguchi, Yoko ; Ogura, Dai ; Kurose, Takahiro ; Moriya, Mariyo ; Arai, Yoko ; Niwa, Shinichiro</creator><creatorcontrib>Mizunuma, Hidemi ; Takai, Yoshihiro ; Mitsuguchi, Yoko ; Ogura, Dai ; Kurose, Takahiro ; Moriya, Mariyo ; Arai, Yoko ; Niwa, Shinichiro</creatorcontrib><description>The existent therapeutic drugs for CNV are merely pharmaceuticals for a symptomatic therapy, and therapeutic drugs for radical cure are strongly demanded. Also, a therapeutic drug for Dry AMD does not exist, and therapeutic drugs for radical cure are strongly demanded. The present invention provides a prophylactic and/or therapeutic agent for choroidal neovascularization, containing a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient. Also, the present invention provides a drusen suppressor comprising a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200901&DB=EPODOC&CC=US&NR=10761087B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200901&DB=EPODOC&CC=US&NR=10761087B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Mizunuma, Hidemi</creatorcontrib><creatorcontrib>Takai, Yoshihiro</creatorcontrib><creatorcontrib>Mitsuguchi, Yoko</creatorcontrib><creatorcontrib>Ogura, Dai</creatorcontrib><creatorcontrib>Kurose, Takahiro</creatorcontrib><creatorcontrib>Moriya, Mariyo</creatorcontrib><creatorcontrib>Arai, Yoko</creatorcontrib><creatorcontrib>Niwa, Shinichiro</creatorcontrib><title>Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same</title><description>The existent therapeutic drugs for CNV are merely pharmaceuticals for a symptomatic therapy, and therapeutic drugs for radical cure are strongly demanded. Also, a therapeutic drug for Dry AMD does not exist, and therapeutic drugs for radical cure are strongly demanded. The present invention provides a prophylactic and/or therapeutic agent for choroidal neovascularization, containing a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient. Also, the present invention provides a drusen suppressor comprising a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi7EKwkAQRNNYiPoPa6-QKBhrg2Kv1mHJbZKDZPfYTVL49ebAykoYGIb3ZplMRSsq3mEHTDKhVWOH6t84eGGwMQQlM1GY43Q0YqhF-1-8A2QHPQ2tuCgAms3AcxOPVikRxxGRYU_rZFFjZ7T59irZ3q7P4r6nICVZwIqYhvL1yNL8lKXn_HI4_uN8ABW5RxM</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Mizunuma, Hidemi</creator><creator>Takai, Yoshihiro</creator><creator>Mitsuguchi, Yoko</creator><creator>Ogura, Dai</creator><creator>Kurose, Takahiro</creator><creator>Moriya, Mariyo</creator><creator>Arai, Yoko</creator><creator>Niwa, Shinichiro</creator><scope>EVB</scope></search><sort><creationdate>20200901</creationdate><title>Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same</title><author>Mizunuma, Hidemi ; Takai, Yoshihiro ; Mitsuguchi, Yoko ; Ogura, Dai ; Kurose, Takahiro ; Moriya, Mariyo ; Arai, Yoko ; Niwa, Shinichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10761087B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>Mizunuma, Hidemi</creatorcontrib><creatorcontrib>Takai, Yoshihiro</creatorcontrib><creatorcontrib>Mitsuguchi, Yoko</creatorcontrib><creatorcontrib>Ogura, Dai</creatorcontrib><creatorcontrib>Kurose, Takahiro</creatorcontrib><creatorcontrib>Moriya, Mariyo</creatorcontrib><creatorcontrib>Arai, Yoko</creatorcontrib><creatorcontrib>Niwa, Shinichiro</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mizunuma, Hidemi</au><au>Takai, Yoshihiro</au><au>Mitsuguchi, Yoko</au><au>Ogura, Dai</au><au>Kurose, Takahiro</au><au>Moriya, Mariyo</au><au>Arai, Yoko</au><au>Niwa, Shinichiro</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same</title><date>2020-09-01</date><risdate>2020</risdate><abstract>The existent therapeutic drugs for CNV are merely pharmaceuticals for a symptomatic therapy, and therapeutic drugs for radical cure are strongly demanded. Also, a therapeutic drug for Dry AMD does not exist, and therapeutic drugs for radical cure are strongly demanded. The present invention provides a prophylactic and/or therapeutic agent for choroidal neovascularization, containing a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient. Also, the present invention provides a drusen suppressor comprising a compound having an activity of suppressing epithelial-mesenchymal transition in retinal pigment epithelial cells, as an active ingredient.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US10761087B2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
| title | Choroidal neovascularization suppressor or drusen formation suppressor, and method for assessing or screening for same |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T15%3A04%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Mizunuma,%20Hidemi&rft.date=2020-09-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10761087B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |